by The Tutu Team | Oct 14, 2016 | Uncategorized
Researchers are reporting clinical activity with the investigational oral compound tucatinib, used as part of combination therapy in patients with advanced breast cancer and skin metastases. Researchers found the drug tucatinib led to a reduction in skin lesions for... 